Skin Disease and Cardiovascular Risk: Uncovering a Critical Clinical Connection
On the Frontlines of PsoriasisSkin Disease and Cardiovascular Risk: Uncovering a Critical Clinical Connection
One Year or Two? DANTE Trial Explores Immunotherapy Duration in Metastatic Melanoma
Project Oncology®One Year or Two? DANTE Trial Explores Immunotherapy Duration in Metastatic Melanoma
What's New in Dermatology: Key Updates on Emerging Therapies
DermConsultWhat's New in Dermatology: Key Updates on Emerging Therapies
Comparing Home and Office-Based UVB Phototherapy: Insights from the LITE Study
On the Frontlines of PsoriasisComparing Home and Office-Based UVB Phototherapy: Insights from the LITE Study
Advancing Wound Care With AI: From Precision Diagnostics to Predictive Insights
Clinician's RoundtableAdvancing Wound Care With AI: From Precision Diagnostics to Predictive Insights
Chronic Wound Healing Time Predicted Through Microbiome and Clinical Data
Clinician's RoundtableChronic Wound Healing Time Predicted Through Microbiome and Clinical Data
- advertisement
Taking Action in Moderate to Severe Pediatric Atopic Dermatitis: Patient- and Caregiver-Centered Approaches to Improve Outcomes
CME/CETaking Action in Moderate to Severe Pediatric Atopic Dermatitis: Patient- and Caregiver-Centered Approaches to Improve Outcomes
Raising the Bar on Obesity Management in Psoriasis and Psoriatic Arthritis: A Collaborative Learning Experience for Dermatology and Rheumatology Healthcare Professionals
CME/CERaising the Bar on Obesity Management in Psoriasis and Psoriatic Arthritis: A Collaborative Learning Experience for Dermatology and Rheumatology Healthcare Professionals
No Patient Left Behind! Advancing CKD-Associated Pruritus Care
CME/CENo Patient Left Behind! Advancing CKD-Associated Pruritus Care
A Clear Horizon in Plaque Psoriasis: Exploring the Role of Investigational Oral Therapies
CME/CEA Clear Horizon in Plaque Psoriasis: Exploring the Role of Investigational Oral Therapies
Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
CME/CEPatient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
Finally, I Can Take a Break from My Itch! Optimizing CKD-aP Treatment
CME/CEFinally, I Can Take a Break from My Itch! Optimizing CKD-aP Treatment
- advertisement
Tailoring Care for Medicare Patients Living with Moderate-to-Severe Plaque Psoriasis
Medical Industry FeatureTailoring Care for Medicare Patients Living with Moderate-to-Severe Plaque Psoriasis
Assessing Cutaneous Squamous Cell Carcinoma in People of Color
Medical Industry FeatureAssessing Cutaneous Squamous Cell Carcinoma in People of Color
Navigating Systemic Therapy Eligibility and Treatment Goals in Psoriasis Care
Medical Industry FeatureNavigating Systemic Therapy Eligibility and Treatment Goals in Psoriasis Care
Best Practices for an Aesthetic Neurotoxin Approach
Medical Industry FeatureBest Practices for an Aesthetic Neurotoxin Approach
- 06/12/2025
- 06/11/2025
- 06/10/2025
- 06/10/2025
- 06/10/2025
- 06/06/2025